We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bayer AG said it plans to spin off its anti-infectives research unit into a new company in which Stuttgart-based Santo Holding Deutschland AG will own a majority holding.
Industry observers have criticised price controls in the drug market
of the United Arab Emirates (UAE), claiming that if such actions are valid for medicines than they should also be used for other areas, such as rent.
Colombia's Attorney General Edgardo Maya has criticised the recent Free Trade Agreement (FTA) with the US, claiming it will have negative effects for the country.
The Czech Republic has one of the lowest annual per capita spending
levels for medicines, according to the International Association of Pharmaceutical Companies in the Czech Republic (MAFS).
Shares in German biotech firm Jerini (JI4G.DE: Quote, Profile, Research) made a turbulent debut on Tuesday, falling 6 percent and then rising 13 percent before closing flat, amid a worsening IPO climate and scepticism about biotech offers.
Caprion Pharmaceuticals Inc. today announced a collaboration agreement with AstraZeneca focused on the discovery of novel targets for the treatment of prostate cancer.
Maruho Company Limited ("Maruho") and SkyePharma PLC announce that they have entered into a strategic agreement for the development, marketing and distribution of DepoBupivacaine(TM) in Japan.
Cambridge Antibody Technology is buying two experimental cancer drugs from a unit of Denmark's Danisco for up to $16 million to boost its drugs pipeline, the UK biotech firm said on Tuesday.
Germany's Altana (ALTG.DE: Quote, Profile, Research) will seek a partner for its drugs unit, it said on Wednesday, as it raised its 2005 earnings target after nine-month profits beat forecasts thanks to strong sales of its flagship drug.